Literature DB >> 32154868

mTORC1 Deficiency Modifies Volume Homeostatic Responses to Dietary Sodium in a Sex-Specific Manner.

Danielle L Brooks1, Amanda E Garza1, Ezgi Caliskan Guzelce1, Shadi K Gholami1, Thitinan Treesaranuwattana1, Stephen Maris1, Sanjay Ranjit1, Chee Sin Tay1, Jessica M Lee1, Jose R Romero1, Gail K Adler1, Luminita H Pojoga1, Gordon H Williams1.   

Abstract

The mechanistic target of the rapamycin (mTOR) pathway plays a role in features common to both excess salt/aldosterone and cardiovascular/renal diseases. Dietary sodium can upregulate mTORC1 signaling in cardiac and renal tissue, and the inhibition of mTOR can prevent aldosterone-associated, salt-induced hypertension. The impact of sex and age on mTOR's role in volume homeostasis and the regulation of aldosterone secretion is largely unknown. We hypothesize that both age and sex modify mTOR's interaction with volume homeostatic mechanisms. The activity of 3 volume homeostatic mechanisms-cardiovascular, renal, and hormonal (aldosterone [sodium retaining] and brain natriuretic peptide [BNP; sodium losing])-were assessed in mTORC1 deficient (Raptor+/-) and wild-type male and female littermates at 2 different ages. The mice were volume stressed by being given a liberal salt (LibS) diet. Raptor+/-mice of both sexes when they aged: (1) reduced their blood pressure, (2) increased left ventricular internal diameter during diastole, (3) decreased renal blood flow, and (4) increased mineralocorticoid receptor expression. Aldosterone levels did not differ by sex in young Raptor+/- mice. However, as they aged, compared to their littermates, aldosterone decreased in males but increased in females. Finally, given the level of Na+ intake, BNP was inappropriately suppressed, but only in Raptor+/- males. These data indicate that Raptor+/- mice, when stressed with a LibS diet, display inappropriate volume homeostatic responses, particularly with aging, and the mechanisms altered, differing by sex. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Raptor; aldosterone; cardiovascular disease; mTOR; salt intake

Mesh:

Substances:

Year:  2020        PMID: 32154868      PMCID: PMC7391217          DOI: 10.1210/endocr/bqaa041

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  77 in total

1.  Rapamycin attenuates aldosterone-induced tubulointerstitial inflammation and fibrosis.

Authors:  Bin Wang; Wei Ding; Minmin Zhang; Hongmei Li; Yong Gu
Journal:  Cell Physiol Biochem       Date:  2015-01-02

2.  Aldosterone Modulates the Mechanistic Target of Rapamycin Signaling in Male Mice.

Authors:  Danielle L Brooks; Amanda E Garza; Isis A Katayama; Jose R Romero; Gail K Adler; Luminita H Pojoga; Gordon H Williams
Journal:  Endocrinology       Date:  2019-04-01       Impact factor: 4.736

3.  A high-frequency, high frame rate duplex ultrasound linear array imaging system for small animal imaging.

Authors:  Lequan Zhang; Xiaochen Xu; Changhong Hu; Lei Sun; Jesse T Yen; Jonathan M Cannata; K Kirk Shung
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-07       Impact factor: 2.725

4.  Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.

Authors:  Sebastian J Buss; Sebastian Muenz; Johannes H Riffel; Pratima Malekar; Marco Hagenmueller; Celine S Weiss; Florian Bea; Raffi Bekeredjian; Martina Schinke-Braun; Seigo Izumo; Hugo A Katus; Stefan E Hardt
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

Review 5.  mTOR, cardiomyocytes and inflammation in cardiac hypertrophy.

Authors:  Lifen Xu; Marijke Brink
Journal:  Biochim Biophys Acta       Date:  2016-01-08

6.  Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure.

Authors:  Amanda J Rickard; James Morgan; Greg Tesch; John W Funder; Peter J Fuller; Morag J Young
Journal:  Hypertension       Date:  2009-07-27       Impact factor: 10.190

7.  Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.

Authors:  C J Sabers; M M Martin; G J Brunn; J M Williams; F J Dumont; G Wiederrecht; R T Abraham
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

Review 8.  Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure.

Authors:  W K Oelkers
Journal:  Steroids       Date:  1996-04       Impact factor: 2.668

Review 9.  Regulation of innate immune cell function by mTOR.

Authors:  Thomas Weichhart; Markus Hengstschläger; Monika Linke
Journal:  Nat Rev Immunol       Date:  2015-10       Impact factor: 53.106

10.  Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth.

Authors:  Yi Zhu; Karla M P Pires; Kevin J Whitehead; Curtis D Olsen; Benjamin Wayment; Yi Cheng Zhang; Heiko Bugger; Olesya Ilkun; Sheldon E Litwin; George Thomas; Sara C Kozma; E Dale Abel
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more
  2 in total

Review 1.  Female Sex, a Major Risk Factor for Salt-Sensitive Hypertension.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Curr Hypertens Rep       Date:  2020-10-21       Impact factor: 5.369

2.  mTORC1 Deficiency Modifies Volume Homeostatic Responses to Dietary Sodium in a Sex-Specific Manner.

Authors:  Danielle L Brooks; Amanda E Garza; Ezgi Caliskan Guzelce; Shadi K Gholami; Thitinan Treesaranuwattana; Stephen Maris; Sanjay Ranjit; Chee Sin Tay; Jessica M Lee; Jose R Romero; Gail K Adler; Luminita H Pojoga; Gordon H Williams
Journal:  Endocrinology       Date:  2020-05-01       Impact factor: 4.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.